OUP accepted manuscript
Author(s) -
Josefine Slater,
Pelle Hanberg,
Mathias Fichtner Bendtsen,
Andrea René Jørgensen,
Eva Greibe,
Kjeld Søballé,
Mats Bue,
Nis Pedersen,
Maiken Stilling
Publication year - 2020
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkaa153
Subject(s) - moxifloxacin , microdialysis , rifampicin , medicine , pharmacokinetics , adipose tissue , cancellous bone , pharmacology , urology , spondylodiscitis , subcutaneous tissue , anesthesia , surgery , antibiotics , chemistry , pathology , tuberculosis , biochemistry , central nervous system
Pyogenic spondylodiscitis remains a therapeutic challenge, as demonstrated by divergent treatment guidelines. The combination of moxifloxacin and rifampicin may be an attractive treatment option for cases caused by staphylococci; however, previous studies have reported a reduction in plasma concentrations of moxifloxacin when coadministered with rifampicin. The magnitude of this reduction in spinal tissues is not known.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom